Akanda Corp. (AKAN) vs Bluejay Diagnostics, Inc. (BJDX)

A side-by-side comparison of Akanda Corp. and Bluejay Diagnostics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Akanda Corp. logo
AKAN
Akanda Corp.
$62628
$1.94HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Bluejay Diagnostics, Inc. logo
BJDX
Bluejay Diagnostics, Inc.
$820321
$0.79HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT

Total return — AKAN vs BJDX

growth of $100 · dividends reinvested · last 5y
AKAN -100.0% (-91.8%/yr)BJDX -100.0% (-87.9%/yr)BJDX compounded faster over this window
Log scale — wide-divergence pair
00001101001kStart $1002023202420252026$0$0
AKAN BJDX

AKAN vs BJDX: by the numbers

  • •BJDX is the larger company ($820321 vs $62628 market cap).
  • •Both run net losses; BJDX's is the smaller (0.00% vs -17690.19% net margin).

Metrics side by side

Valuation

MetricAKANBJDX
P/B ratioN/A0.09

Profitability

MetricAKANBJDX
Gross margin-60.46%0.00%
Operating margin-1930.99%0.00%
Net margin-17690.19%0.00%
ROEN/A-77.23%
ROIC-242.09%-77.55%

Growth (annualized)

MetricAKANBJDX
Revenue CAGR (5Y)162.75%N/A

Go deeper

Full AKAN analysisFull BJDX analysisInteractive comparison tool

Dig into the metrics

Akanda ROEBluejay Diagnostics ROEAkanda operating marginBluejay Diagnostics operating marginAkanda revenue growthBluejay Diagnostics revenue growthAkanda free cash flowBluejay Diagnostics free cash flow

Akanda & Bluejay Diagnostics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.